Barclays’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.8M | Sell |
86,405
-141,038
| -62% | -$25.6M | ﹤0.01% | 1137 |
|
|
2026
Q1 | $30.3M | Buy |
227,443
+1,013
| +0.4% | +$161K | 0.01% | 929 |
|
|
2025
Q4 | $39.3M | Buy |
226,430
+116,356
| +106% | +$19.1M | 0.01% | 896 |
|
|
2025
Q3 | $21.1M | Sell |
110,074
-36,268
| -25% | -$6.68M | ﹤0.01% | 1208 |
|
|
2025
Q2 | $43.6M | Sell |
146,342
-17,359
| -11% | -$5.45M | 0.01% | 765 |
|
|
2025
Q1 | $53.9M | Sell |
163,701
-8,916
| -5% | -$2.69M | 0.02% | 626 |
|
|
2024
Q4 | $50.2M | Sell |
172,617
-23,291
| -12% | -$7.19M | 0.01% | 660 |
|
|
2024
Q3 | $67.5M | Sell |
195,908
-2,777
| -1% | -$916K | 0.02% | 569 |
|
|
2024
Q2 | $59.1M | Buy |
198,685
+26,279
| +15% | +$8.92M | 0.02% | 564 |
|
|
2024
Q1 | $70.8M | Buy |
172,406
+37,140
| +27% | +$14.4M | 0.02% | 483 |
|
|
2023
Q4 | $48.9M | Buy |
135,266
+9,706
| +8% | +$3.42M | 0.02% | 683 |
|
|
2023
Q3 | $41.2M | Sell |
125,560
-63,479
| -34% | -$20M | 0.03% | 543 |
|
|
2023
Q2 | $56.9M | Buy |
189,039
+63,128
| +50% | +$18.1M | 0.04% | 413 |
|
|
2023
Q1 | $33.7M | Buy |
125,911
+24,826
| +25% | +$7.13M | 0.02% | 629 |
|
|
2022
Q4 | $33.4M | Buy |
101,085
+34,869
| +53% | +$11.8M | 0.01% | 659 |
|
|
2022
Q3 | $21.8M | Buy |
66,216
+6,686
| +11% | +$2.15M | 0.02% | 584 |
|
|
2022
Q2 | $16.6M | Sell |
59,530
-19,375
| -25% | -$5.85M | 0.01% | 794 |
|
|
2022
Q1 | $26.3M | Buy |
78,905
+19,077
| +32% | +$5.87M | 0.02% | 593 |
|
|
2021
Q4 | $19M | Sell |
59,828
-54,759
| -48% | -$16.3M | 0.01% | 961 |
|
|
2021
Q3 | $31.1M | Buy |
114,587
+29,308
| +34% | +$7.74M | 0.01% | 705 |
|
|
2021
Q2 | $21.6M | Buy |
85,279
+33,162
| +64% | +$8.33M | 0.01% | 862 |
|
|
2021
Q1 | $12.2M | Buy |
52,117
+7,230
| +16% | +$1.61M | 0.01% | 1002 |
|
|
2020
Q4 | $9.55M | Buy |
44,887
+7,652
| +21% | +$1.58M | 0.01% | 1177 |
|
|
2020
Q3 | $6.82M | Buy |
37,235
+8,602
| +30% | +$1.57M | ﹤0.01% | 1221 |
|
|
2020
Q2 | $5.1M | Buy |
28,633
+26,356
| +1,157% | +$4.49M | ﹤0.01% | 1371 |
|
|
2020
Q1 | $318K | Sell |
2,277
-110,603
| -98% | -$14.8M | ﹤0.01% | 3951 |
|
|
2019
Q4 | $15.3M | Buy |
112,880
+98,424
| +681% | +$12.4M | 0.01% | 1105 |
|
|
2019
Q3 | $1.59M | Sell |
14,456
-59,912
| -81% | -$7.76M | ﹤0.01% | 3153 |
|
|
2019
Q2 | $10.6M | Buy |
74,368
+60,831
| +449% | +$8.33M | 0.01% | 1315 |
|
|
2019
Q1 | $1.92M | Sell |
13,537
-11,158
| -45% | -$1.51M | ﹤0.01% | 2611 |
|
|
2018
Q4 | $2.87M | Sell |
24,695
-30,256
| -55% | -$3.97M | ﹤0.01% | 2050 |
|
|
2018
Q3 | $8.17M | Sell |
54,951
-25,045
| -31% | -$3.2M | 0.01% | 1402 |
|
|
2018
Q2 | $7.84M | Sell |
79,996
-50
| -0.1% | -$4.36K | 0.01% | 1400 |
|
|
2018
Q1 | $6.5M | Sell |
80,046
-9,074
| -10% | -$730K | 0.01% | 1448 |
|
|
2017
Q4 | $6.83M | Sell |
89,120
-44,854
| -33% | -$3.24M | 0.01% | 1427 |
|
|
2017
Q3 | $9.21M | Buy |
133,974
+68,722
| +105% | +$4.47M | 0.01% | 1105 |
|
|
2017
Q2 | $4.51M | Buy |
65,252
+50,020
| +328% | +$3.07M | ﹤0.01% | 1552 |
|
|
2017
Q1 | $695K | Sell |
15,232
-67,216
| -82% | -$3.52M | ﹤0.01% | 3078 |
|
|
2016
Q4 | $4.47M | Buy |
82,448
+80,927
| +5,321% | +$4.43M | ﹤0.01% | 1457 |
|
|
2016
Q3 | $88K | Sell |
1,521
-3,686
| -71% | -$203K | ﹤0.01% | 4600 |
|
|
2016
Q2 | $259K | Sell |
5,207
-26,342
| -83% | -$1.41M | ﹤0.01% | 3735 |
|
|
2016
Q1 | $2.02M | Buy |
31,549
+23,585
| +296% | +$1.4M | ﹤0.01% | 1911 |
|
|
2015
Q4 | $477K | Sell |
7,964
-25,911
| -76% | -$1.63M | ﹤0.01% | 3260 |
|
|
2015
Q3 | $2.3M | Buy |
33,875
+32,249
| +1,983% | +$2.39M | ﹤0.01% | 2002 |
|
|
2015
Q2 | $114K | Sell |
1,626
-900
| -36% | -$60.2K | ﹤0.01% | 4573 |
|
|
2015
Q1 | $170K | Sell |
2,526
-4,822
| -66% | -$279K | ﹤0.01% | 4464 |
|
|
2014
Q4 | $389K | Sell |
7,348
-68,754
| -90% | -$3.33M | ﹤0.01% | 4105 |
|
|
2014
Q3 | $3.2M | Sell |
76,102
-6,052
| -7% | -$268K | ﹤0.01% | 2224 |
|
|
2014
Q2 | $3.61M | Buy |
82,154
+56,034
| +215% | +$2.27M | ﹤0.01% | 2045 |
|
|
2014
Q1 | $967K | Sell |
26,120
-23,639
| -48% | -$871K | ﹤0.01% | 3269 |
|
|
2013
Q4 | $1.69M | Sell |
49,759
-87,780
| -64% | -$2.96M | ﹤0.01% | 2842 |
|
|
2013
Q3 | $4.81M | Buy |
137,539
+107,071
| +351% | +$3.95M | 0.01% | 1717 |
|
|
2013
Q2 | $1.13M | Buy |
+30,468
| New | +$1.08M | ﹤0.01% | 3205 |
|
Other funds holding MOH
LIM
Barclays's MOH Position: Q2 2026 in Review
Barclays reduced its Molina Healthcare (MOH) stake by 62% in Q2 2026, selling an estimated $25.6M and leaving 86,405 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1137.
Barclays first reported a position in MOH in Q2 2013 and has held it in 53 quarters since. The position peaked at $70.8M in Q1 2024. 598 funds tracked by Wall St. Rank hold MOH as of Q2 2026.
- Barclays held 86,405 shares of Molina Healthcare worth $19.8M as of Q2 2026.
- Barclays sold 141,038 Molina Healthcare shares in Q2 2026, an estimated $25.6M.
- Molina Healthcare made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1137 holding.
- Barclays first reported a position in Molina Healthcare in Q2 2013 and has held it in 53 quarters since.
- Barclays's Molina Healthcare position peaked at $70.8M in Q1 2024.
- 598 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.